CLINICAL_TRIALS
trial_result
· 2010-12-23
Clinical Trial Update: Genotropin Study Assessing Use of Injection Pen [Phase 3]
Summary
Pfizer's Genotropin Phase 3 trial evaluating an injection pen for growth hormone deficiency and idiopathic short stature has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Growth Hormone Deficiency, Idiopathic Short Stature | Phase 3 | Status: COMPLETED | Results posted: 2010-12-23